TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study E Tobinick, H Gross, A Weinberger, H Cohen Medscape General Medicine 8 (2), 25, 2006 | 386 | 2006 |
Cytokine antagonists for the treatment of localized disorders EL Tobinick, E Sutton, TK Page, L Channavajjala US Patent 6,537,549, 2003 | 323 | 2003 |
Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration EL Tobinick, H Gross Journal of neuroinflammation 5, 1-10, 2008 | 322 | 2008 |
The value of drug repositioning in the current pharmaceutical market. EL Tobinick Drug news & perspectives 22 (2), 119-125, 2009 | 282 | 2009 |
Right ventricular ejection fraction in patients with acute anterior and inferior myocardial infarction assessed by radionuclide angiography KJS Tobinick E, Schelbert HR, Henning H, LeWinter M, Taylor A, Ashburn WL Circulation 57 (6), 1078-84, 1978 | 241 | 1978 |
Tumor necrosis factor antagonists for the treatment of neurological disorders EL Tobinick, AJ Tobinick US Patent 6,015,557, 2000 | 187 | 2000 |
Cytokine antagonists for neurological and neuropsychiatric disorders EL Tobinick US Patent 6,982,089, 2006 | 162 | 2006 |
Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept E Tobinick, NM Kim, G Reyzin, H Rodriguez-Romanacce, V DePuy CNS drugs 26, 1051-1070, 2012 | 159 | 2012 |
TNT inhibitors for the treatment of neurological disorders EL Tobinick US Patent 6,177,077, 2001 | 157 | 2001 |
The cerebrospinal venous system: anatomy, physiology, and clinical implications E Tobinick, CP Vega MedGenMed 8 (1), 53, 2006 | 151 | 2006 |
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease EL Tobinick, H Gross BMC neurology 8, 1-9, 2008 | 146 | 2008 |
Tumour necrosis factor modulation for treatment of Alzheimer’s disease: rationale and current evidence E Tobinick CNS drugs 23, 713-725, 2009 | 138 | 2009 |
Perispinal TNF-alpha inhibition for discogenic pain EL Tobinick, S Britschgi-Davoodifar Swiss medical weekly 133 (1112), 170-170, 2003 | 138 | 2003 |
TNF inhibitors for the treatment of neurological, retinal and muscular disorders EL Tobinick US Patent 6,379,666, 2002 | 127 | 2002 |
Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients E Tobinick, S Davoodifar Current medical research and opinion 20 (7), 1075-1085, 2004 | 126 | 2004 |
TNF modulators for treating neurological disorders associated with viral infection EL Tobinick US Patent 6,419,934, 2002 | 118 | 2002 |
Cytokine antagonists for the treatment of sensorineural hearing loss EL Tobinick US Patent 6,423,321, 2002 | 108 | 2002 |
Perispinal etanercept for treatment of Alzheimer's disease E Tobinick Current Alzheimer Research 4 (5), 550-552, 2007 | 102 | 2007 |
Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers EL Tobinick US Patent 7,629,311, 2009 | 98 | 2009 |
Perispinal etanercept: a new therapeutic paradigm in neurology E Tobinick Expert review of neurotherapeutics 10 (6), 985-1002, 2010 | 85 | 2010 |